Find Cancer Up to 4 Years Before Symptoms?! (It’s Possible)

When it comes to beating cancer, time is not on your side.

Your best bet for a good outcome is to identify the cancer as early as possible, when it is more treatable—and before it has spread to other parts of your body.

If you don’t get tested until symptoms crop up, you’ve already wasted valuable time.

But now, scientists have developed a revolutionary new blood test that can identify the presence of cancer up to FOUR YEARS before any symptoms develop.

This could be a game-changer in the fight against cancer.

This new blood test—called the PanSeer—is based on using a type of artificial intelligence to screen blood plasma for specific methyl groups that show up in cancer DNA.

Researchers used blood samples from 414 people who remained cancer-free five years after their blood was taken, and used 191 samples from people who were diagnosed with cancer within four years of the blood draw.

The results were impressive.

• PanSeer accurately identified cancer in 88 percent of participants who had already received a cancer diagnosis.
• It accurately identified cancer in 95 percent of patients who were NOT diagnosed with cancer but later DID receive a cancer diagnosis.
• It also correctly identified those who did NOT go on to develop cancer 96 percent of the time.

The type of cancers that the participants developed included stomach, colorectal, liver, lung, and esophageal cancers—which indicates that these types of cancer can be detected by the test.

However, while the test could identify the presence of cancer, it could not identify the specific type someone had.

This type of test is referred to as a liquid biopsy, and previous studies have also seen encouraging results.

For example, one team found that a liquid biopsy could identify 10 different types of cancer at an early stage.

There are many types of cancer that have no current screening tests available. If the PanSeer and other types of liquid biopsies continue to prove themselves in larger studies, they could fill a critical gap in the cancer screening process.

Remember, prevention is best, but early detection is next.